Filing Details

Accession Number:
0001415889-23-006359
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-07 16:30:16
Reporting Period:
2023-04-06
Accepted Time:
2023-04-07 16:30:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750284 Olema Pharmaceuticals Inc. OLMA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579397 Charles William Shane Kovacs C/O Olema Pharmaceuticals, Inc.
512 2Nd Street, 4Th Floor
San Francisco CA 94107
Ch. Operating & Financial Off. No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-06 10,000 $0.00 396,197 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The weighted average purchase price for the transaction reported was $3.4173, and the range of prices were between $3.375 and $3.42. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.
  2. Includes 5,000 shares acquired under the issuer's Employee Stock Purchase Plan.